Palvella Therapeutics, Inc. (PVLA)

NASDAQ: PVLA · Real-Time Price · USD

156.85

-5.43 (-3.35%)

Nov 5, 2026, 4:00 PM EST - Market closed

Palvella Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Income	-70.29	-38.6	-14.1	-11.87	-18.04
Net Income	-74.99	-41.72	-17.43	3.88	-27.55
Earnings Per Share	-5.57	-3.71	-7.83	2.17	-4.82
EPS Growth	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	236.68	57.98	83.6	7.35	16.05
Total Debt	25.41	18.39	11.94	8.05	32.42
Net Cash (Debt)	211.27	39.59	71.66	-0.7	-16.36
Net Cash Growth	344.36%	-44.75%	-	-	-
Net Cash Per Share	15.69	3.52	32.19	-0.39	-2.86

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	-43.06	-25.01	-10.84	-13.7	-14.84
Free Cash Flow	-43.06	-25.01	-10.84	-13.7	-14.84
Free Cash Flow Growth	-	-	-	-	-

Valuation

Selected indicators aren't available for this stock.